US removes Defense Production Act ratings for some vaccines

The U.S. recently removed priority ratings from vaccine orders from Novavax, AstraZeneca and Sanofi. (Photo: Novavax)

This is an excerpt from Medically Necessary, a health care supply chain newsletterSubscribe here.

The decision: Last week, the U.S. announced it was removing the priority ratings issued under the Defense Production Act for vaccines made by Sanofi, AstraZeneca and Novavax. Orders for other vaccines remain prioritized.

The Defense Production Act, or DPA, allows the president to place priority ratings on government orders, which compels companies to accept and prioritize those orders.  Companies...

Leave a Comment

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.